Schneider Blocker’s Vision and Mission

about-img

Our vision is to become a leading pharmaceutical company with focus on sustaining growth and profitability to provide value for our patients, shareholders and community. We strive to be a growth-maintaining, innovative company that is open to different kinds of commercial models and market - leading in certain therapeutical areas with prescription and non-prescription (Rx and OTC) products. We are dedicated to products that serve society by increasing the well-being and quality of life of individuals. As a company, our aim is to attract the best talent and reward our employees for outstanding performance. Maintaining our excellent reputation is vital to us

Business Development

about-img

Schneider Blocker’s ambition is to become a leading pharmaceutical company. Schneider Blocker pursues this via development and introduction of new products, product rights, long-term partnerships and presence in growing markets.

Business development plays an important role in Schneider Blocker. Personal contacts, industry networks, scientific skills, and market knowledge are important factors for success.

Schneider Blocker’s management continually assesses numerous acquisition and partnership opportunities.

For a personal contact or more information about partnering with Schneider Blocker, please e-mail:info@schneiderblocker.com

Product Development

about-img

Schneider Blocker is active in clinical development in partnership with various R&D centers in Asia and the development process has 100 dedicated minds who work on development, clinical trails and drug registration.

The value-generating work performed in Schneider Blocker’s development department is focused on tailored clinical development programs and the compilation of scientific arguments defending, exploring and highlighting product features. Through experience and scientific arguments, Schneider Blocker refrains from high-risk, capital-intensive early reserch. Instead the company’s resources are concentrated on development ‘close to market’ in the late clinical or registration phases. The focus is often on well-known active ingredients and improving the characteristics of existing products.

Manufacturing and Supply Chain

about-img

Schneider Blocker mainly sources out its production to well know contract manufacturing facilities, this enable Schneider Blocker to focus on development and regulatory registration along with cost efficiency for better value for patients and growth sustainability.